483
Shandong Anhong Pharmaceutical Co., Ltd.Shandong Anhong Pharmaceutical Co., Ltd. – FDA 483, Oct 30, 2020
Record Details
Shandong Anhong Pharmaceutical Co., Ltd. was cited for significant deficiencies in its manufacturing processes and quality control systems. Observations include inadequate cleaning and disinfection procedures, failure to follow sterile product contamination prevention protocols, and insufficient laboratory controls for impurity evaluation. These issues indicate a moderate to severe risk to product quality and patient safety.
View Company Profile
ID · 9f201cbb-010b-412d-b8a8-04838f3940ff
Other documents for Shandong Anhong Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.